Identification of key structural features of phosphate and thiophosphate tricyclic coumarin analogs as STS inhibitors
Tóm tắt
Steroidal sulfatase (STS) is a group of arylsulfatase C enzymes that are involved in the metabolism of steroids. The increase in the circulation of the steroidogenic hormone Estradiol (E2) is responsible for causing breast cancer. Therefore, inhibitors of STS are proved to be an attractive target in the development of lead molecules against breast malignancy. In this work, Quantitative Structural Activity Relationship (QSAR) studies were performed on a dataset of 72 molecules of tricyclic coumarin analogs using random selection in QSARINS software and the statistical technique Genetic Algorithm coupled Multiple Linear Regression (MLR) was employed with the best model prediction R2 = 0.86 and Q2 loo = 0.7913. The inclusion of descriptors Mor15m and Mor18v has developed a well-fitted and highly predictable model. Furthermore, the molecular docking and dynamics simulations helped us identify the binding interactions and estimate the stability of the complexes respectively. The binding analysis of the compounds into human sulfatase protein (PDB code: 1P49) resulted in prominent hydrophobic interactions with Arg98, Val486, Phe488, Gly100, Val101, and Lys368. The top-scoring compound 9o and compound 41 were studied for stability analysis in comparison with the standard Irosustat and the RMSD was found to be 5.4 Å. Based on our findings, we report the inclusion of the necessary structural features of coumarin derivatives leads to the development of potent candidates for further development.
Từ khóa
#Tricyclic coumarin analogs #QSARINS #Molecular docking #Molecular dynamicsTài liệu tham khảo
[1] F. Bray J. Ferlay I. Soerjomataram R.L. Siegel L.A. Torre A. Jemal Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 68 6 2018 394 424 10.3322/caac.21492 Bray F, Ferlay J, Soerjomataram I, et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424. 10.3322/caac.21492
[2] K. Dahlman-Wright V. Cavailles S.A. Fuqua International union of pharmacology. LXIV. Estrogen receptors Pharmacol. Rev. 58 2006 773 781 Dahlman-Wright K, Cavailles V, Fuqua SA, et al (2006) International union of pharmacology. LXIV. Estrogen receptors. Pharmacol. Rev. 58:773–781
[3] A. Majumder M. Singh S.C. Tyagi Post-menopausal breast cancer: From estrogen to androgen receptor Oncotarget 8 60 2017 102739 102758 Majumder A, Singh M, Tyagi SC (2017) Post-menopausal breast cancer: From estrogen to androgen receptor. Oncotarget 8:102739–102758
[4] S.S. Ahmed V. Ramakrishnan Systems biological approach of molecular descriptors connectivity: optimal descriptors for oral bioavailability prediction PLoS One 16 2012 e40654 10.1371/journal.pone.0040654 Ahmed S S, Ramakrishnan V (2012). Systems biological approach of molecular descriptors connectivity: optimal descriptors for oral bioavailability prediction. PLoS One, 16: e40654. 10.1371/journal.pone.0040654
[5] J. Russo X. Ao C. Grill I.H. Russo Pattern of distribution of cells positive for estrogen receptor a and progesterone receptor about proliferating cells in the mammary gland Breast Cancer Res Treat 53 1999 217 227 10.1023/A:1006186719322 Russo J, Ao X, Grill C, Russo IH (1999) Pattern of distribution of cells positive for estrogen receptor a and progesterone receptor about proliferating cells in the mammary gland. Breast Cancer Res Treat 53:217–227. 10.1023/A:1006186719322
[6] J. Russo I.H. Russo Molecular basis of pregnancy-induced breast cancer prevention Horm. Mol. Biol. Clin. Investig. 9 2012 3 10 10.1097/00008469-200608000-00006 Russo J, Russo IH (2012). Molecular basis of pregnancy-induced breast cancer prevention. Horm. Mol. Biol. Clin. Investig. 9:3-10. 10.1097/00008469-200608000-00006
[7] A. Mallick S. Taylor Therapeutic potential of estradiol in treating breast cancer Breast Cancer Manag 8 2 2019 BMT27 10.2217/bmt-2019-0013 Mallick A, Taylor S (2019) Therapeutic potential of estradiol in treating breast cancer. Breast Cancer Manag 8:BMT27. 10.2217/bmt-2019-0013
[8] N. Heldring A. Pike S. Andersson J. Matthews G. Cheng J. Hartman Estrogen receptors: How do they signal and what are their targets Physiol. Rev. 87 3 2007 905 931 Heldring N, Pike A, Andersson S, et al (2007) Estrogen receptors: How do they signal and what are their targets. Physiol. Rev. 87:905–931
[9] A. Lipton S.J. Santner R.J. Santen H.A. Harvey P.D. Feil D. White-Hershey Aromatase activity in primary and metastatic human breast cancer Cancer 59 4 1987 779 782 10.1002/(ISSN)1097-014210.1002/1097-0142(19870215)59:4<>1.0.CO;2-O10.1002/1097-0142(19870215)59:4<779::AID-CNCR2820590419>3.0.CO;2-U Lipton A, Santner SJ, Santen RJ, et al (1987) Aromatase activity in primary and metastatic human breast cancer. Cancer 59:779–782. 10.1002/1097-0142(19870215)59:4<779::AID-CNCR2820590419>3.0.CO;2-U
[10] J.R. Pasqualini G.S. Chetrite Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer J Steroid Biochem Mol Biol 2005 221 236 Pasqualini JR, Chetrite GS (2005) Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer. In: Journal of Steroid Biochemistry and Molecular Biology. pp 221–236
[11] E. Sasaki N. Tsunoda Y. Hatanaka N. Mori H. Iwata Y. Yatabe Breast-specific expression of MGB1/mammaglobin: an examination of 480 tumors from various organs and clinicopathological analysis of MGB1-positive breast cancers Mod Pathol 20 2 2007 208 214 10.1038/modpathol.3800731 Sasaki E, Tsunoda N, Hatanaka Y, et al (2007). Breast-specific expression of MGB1/mammaglobin: an examination of 480 tumors from various organs and clinicopathological analysis of MGB1-positive breast cancers. Modern pathology. 20:208-14. 10.1038/modpathol.3800731
[12] B. Westley H. Rochefort A secreted glycoprotein induced by estrogen in human breast cancer cell lines Cell 20 1980 353 362 10.1016/0092-8674(80)90621-2 Westley B, Rochefort H (1980). A secreted glycoprotein induced by estrogen in human breast cancer cell lines. Cell. 20: 353-62. 10.1016/0092-8674(80)90621-2
[13] Endogenous Hormones and Breast Cancer Collaborative Group Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies J. Natl. Cancer Inst. Monogr. 94 2002 606 616 10.1093/jnci/94.8.606 Endogenous Hormones and Breast Cancer Collaborative Group (2002). Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J. Natl. Cancer Inst. Monogr. 94:606-16. 10.1093/jnci/94.8.606
[14] E. Folkerd M. Dowsett Sex hormones and breast cancer risk and prognosis Breast 22 2013 S38 S43 10.1016/j.breast.2013.07.007 Folkerd E, Dowsett M (2013) Sex hormones and breast cancer risk and prognosis. Breast 22:10.1016/j.breast.2013.07.007
null
[16] G.S. Chetrite J. Cortes-Prieto J.C. Philippe F. Wright J.R. Pasqualini Comparison of estrogen concentrations, estrone sulfatase, and aromatase activities in normal, and in cancerous, human breast tissues J Steroid Biochem Mol Biol 72 1-2 2000 23 27 10.1016/S0960-0760(00)00040-6 Chetrite GS, Cortes-Prieto J, Philippe JC, et al (2000) Comparison of estrogen concentrations, estrone sulfatase, and aromatase activities in normal, and in cancerous, human breast tissues. J Steroid Biochem Mol Biol 72:23–27. 10.1016/S0960-0760(00)00040-6
[17] T.R.J. Evans M.G. Rowlands M. Jarman R.C. Coombes Inhibition of estrone sulfatase enzyme in human placenta and human breast carcinoma J Steroid Biochem Mol Biol 39 4 1991 493 499 10.1016/0960-0760(91)90243-X Evans TJ, Rowlands MG, Jarman M, et al (1991) Inhibition of estrone sulfatase enzyme in human placenta and human breast carcinoma. J Steroid Biochem Mol Biol 39:493-9. 10.1016/0960-0760(91)90243-x
[18] S.J. Stanway A. Purohit L.W.L. Woo S. Sufi D. Vigushin R. Ward Phase I study of STX 64 (667 Coumate) in breast cancer patients: The first study of a steroid sulfatase inhibitor Clin Cancer Res 12 5 2006 1585 1592 10.1158/1078-0432.CCR-05-1996 Stanway SJ, Purohit A, Woo LWL, et al (2006) Phase I study of STX 64 (667 Coumate) in breast cancer patients: The first study of a steroid sulfatase inhibitor. Clin Cancer Res 12:1585–1592. 10.1158/1078-0432.CCR-05-1996
[19] M. Daśko S. Demkowicz K. Biernacki Recent progress in the development of steroid sulphatase inhibitors–examples of the novel and most promising compounds from the last decade J Enzyme Inhib Med Chem. 35 2020 1163 1184 10.1080/14756366.2020.1758692 Daśko M, Demkowicz S, Biernacki K, et al (2020). Recent progress in the development of steroid sulphatase inhibitors–examples of the novel and most promising compounds from the last decade. J Enzyme Inhib Med Chem. 35:1163-84.
[20] L.W.L. Woo N.M. Howarth A. Purohit H.A.M. Hejaz M.J. Reed B.V.L. Potter Steroidal and nonsteroidal sulfamates as potent inhibitors of steroid sulfatase J Med Chem 41 7 1998 1068 1083 10.1021/jm970527v Woo LWL, Howarth NM, Purohit A, et al (1998) Steroidal and nonsteroidal sulfamates as potent inhibitors of steroid sulfatase. J Med Chem 41:1068–1083. 10.1021/jm970527v
[21] R. Srimathi M.K. Kathiravan Lead optimization of 4-(thio)-chromenone 6-O-sulfamate analogs using QSAR, molecular docking, and DFT–a combined approach as steroidal sulfatase inhibitors J Receptor Signal Transduct Res 41 2021 123 137 10.1080/10799893.2020.1794004 Srimathi R, Kathiravan MK (2021). Lead optimization of 4-(thio)-chromenone 6-O-sulfamate analogs using QSAR, molecular docking, and DFT–a combined approach as steroidal sulfatase inhibitors. Journal of receptor and signal transduction research. 41:123-37. 10.1080/10799893.2020.1794004
[22] W. Kozak M. Daśko M. Masłyk J.S. Pieczykolan B. Gielniewski J. Rachon Phosphate tricyclic coumarin analogs as steroid sulfatase inhibitors: Synthesis and biological activity RSC Adv 4 84 2014 44350 44358 10.1039/C4RA07135B Kozak W, Das̈ko M, Masłyk M, et al (2014) Phosphate tricyclic coumarin analogs as steroid sulfatase inhibitors: Synthesis and biological activity. RSC Adv 4:44350–44358. 10.1039/c4ra07135b
[23] P. Gramatica N. Chirico E. Papa S. Cassani S. Kovarich QSARINS: A new software for the development, analysis, and validation of QSAR MLR models J Comput Chem 34 24 2013 2121 2132 10.1002/jcc.v34.2410.1002/jcc.23361 Gramatica P, Chirico N, Papa E, et al (2013) QSARINS: A new software for the development, analysis, and validation of QSAR MLR models. J Comput Chem 34:2121–2132. 10.1002/jcc.23361
null
[25] N.M. O'Boyle M. Banck C.A. James C. Morley T. Vandermeersch G.R. Hutchison Open Babel: An Open chemical toolbox J Cheminform 3 1 2011 10.1186/1758-2946-3-33 O’Boyle NM, Banck M, James CA, et al (2011) Open Babel: An Open chemical toolbox. J Cheminform 3: 10.1186/1758-2946-3-33
[26] M.D. Hanwell D.E. Curtis D.C. Lonie T. Vandermeersch E. Zurek G.R. Hutchison Avogadro: An advanced semantic chemical editor, visualization, and analysis platform J Cheminform 4 1 2012 10.1186/1758-2946-4-17 Hanwell MD, Curtis DE, Lonie DC, et al (2012) Avogadro: An advanced semantic chemical editor, visualization, and analysis platform. J Cheminform 4: 10.1186/1758-2946-4-17
[27] H. Moriwaki Y.S. Tian N. Kawashita Mordred: a molecular descriptor calculator J Cheminform 10 2018 1 4 Moriwaki H, Tian YS, Kawashita N, et al (2018). Mordred: a molecular descriptor calculator. Journal of cheminformatics. 10:1-4.
[28] A.K. Saxena P. Prathipati Comparison of MLR, PLS and GA-MLR in QSAR analysis SAR and QSAR in Environmental Research 2003 433 445 Saxena AK, Prathipati P (2003) Comparison of MLR, PLS and GA-MLR in QSAR analysis. In: SAR and QSAR in Environmental Research. pp 433–445
[29] P. Gramatica Principles of QSAR models validation: internal and external QSAR Comb. Sci. 26 2007 694 701 Gramatica P (2007) Principles of QSAR models validation: internal and external. QSAR Comb. Sci. 26:694–701
[30] N. Chirico P. Gramatica The real external predictivity of QSAR models: how to evaluate it? Comparison of different validation criteria and proposal of using the concordance correlation coefficient J Chem Inf Model. 51 2011 2320 2335 Chirico N, Gramatica P (2011). The real external predictivity of QSAR models: how to evaluate it? Comparison of different validation criteria and proposal of using the concordance correlation coefficient. J Chem Inf Model. 51:2320-35.
null
[32] L. Jendele R. Krivak P. Skoda PrankWeb: a web server for ligand binding site prediction and visualization Nucleic Acids Res 47 W1 2019 W345 W349 Jendele L, Krivak R, Skoda P, et.al (2019). PrankWeb: a web server for ligand binding site prediction and visualization. Nucleic acids research. 47(W1): W345-9.
[33] J. Haribabu G.R. Subhashree S. Saranya Synthesis, crystal structure, and in vitro and silico molecular docking of novel acyl thiourea derivatives J. Mol. Struct. 1094 2015 281 291 Haribabu J, Subhashree GR, Saranya S et.al(2015). Synthesis, crystal structure, and in vitro and silico molecular docking of novel acyl thiourea derivatives. J.Mol.Struct.1094:281-91.
null
[35] N.S. Vyawahare A.A. Hadambar A.S. Chothe Effect of novel synthetic evodiamine analog on sexual behavior in male rats J. Chem. Biol. 5 2012 35 42 Vyawahare NS, Hadambar AA, Chothe AS,et .al (2012). Effect of novel synthetic evodiamine analog on sexual behavior in male rats. J. Chem. Biol. 5:35-42
null
[37] B. Shanthakumar M.K. Kathiravan Insights into structures of imidazole oxazines as potent polyketide synthase XIII inhibitors using molecular modeling techniques J. Recept. Signal Transduct. 40 2020 313 323 Shanthakumar B, Kathiravan MK (2020). Insights into structures of imidazole oxazines as potent polyketide synthase XIII inhibitors using molecular modeling techniques. J. Recept. Signal Transduct. 40:313-23.
null
[39] D.E. Pires T.L. Blundell D.B. Ascher pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures J. Med. Chem. 58 2015 4066 4072 Pires DE, Blundell TL, Ascher DB (2015). pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J.Med.Chem. 58:4066-72.
[40] A. Daina O. Michielin V. Zoete SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness, and medicinal chemistry friendliness of small molecules Sci. Rep. 2017 7 2017 1 3 Daina A, Michielin O, Zoete V (2017). SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness, and medicinal chemistry friendliness of small molecules. Sci. Rep.2017; 7:1-3.